Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test

Toshihiko Kakiuchi1, Kazutoshi Hashiguchi2, Ichiro Imamura2

  • 1Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan. kakiucht@cc.saga-u.ac.jp.

BMC Gastroenterology
|November 24, 2020
PubMed

Insights

A new nested polymerase chain reaction-quenching probe (Nested PCR-QP) method effectively detects clarithromycin (CAM)-resistant Helicobacter pylori in children and adults using stool samples. This minimally invasive approach aids in selecting appropriate treatment to reduce eradication failure rates.

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Clinical Medicine

Background:

  • High rates of Helicobacter pylori resistance to clarithromycin (CAM) in Japanese children necessitate novel detection methods.
  • Minimally invasive techniques for identifying CAM-resistant H. pylori are crucial for effective treatment.

Purpose of the Study:

  • To evaluate the clinical utility of a newly developed nested polymerase chain reaction-quenching probe (Nested PCR-QP) method.
  • To assess the feasibility of using stool specimens for detecting CAM resistance mutations in H. pylori.

Main Methods:

  • The Nested PCR-QP method was initially validated using residual solutions from H. pylori stool antigen tests in adolescents.
  • Subsequently, the method was evaluated in adults using culture testing for H. pylori confirmation.

Main Results:

  • The Nested PCR-QP method successfully analyzed stool samples from 90.3% of 57 H. pylori-infected middle school students.
  • CAM resistance mutations were identified in 28 students, with results consistent with PCR-direct sequencing.
  • In adults, the Nested PCR-QP method showed consistent results with drug susceptibility testing for detecting resistance mutations.

Conclusions:

  • The novel Nested PCR-QP method offers a non-invasive approach for detecting CAM resistance mutations in H. pylori.
  • This diagnostic tool has the potential to improve treatment selection and reduce H. pylori eradication failure rates.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
784
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
374
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
584